Form 4: QuidelOrtho Director Buys 370 Shares

QuidelOrtho Corp Director Joseph D. Wilkins Jr. purchased 370 shares of common stock at $27.955 per share, increasing his direct beneficial ownership.

Summary

• Joseph D. Wilkins Jr., a Director of QuidelOrtho Corp (QDEL), acquired 370 shares of common stock.
• The transaction occurred on November 26, 2025, at a price of $27.955 per share.
• Following this purchase, Mr. Wilkins directly beneficially owns a total of 11,876 shares of QuidelOrtho Corp common stock.

Sentiment

Score: 7

Explanation: An insider purchase by a director is a moderately positive signal, indicating confidence in the company's future, though the size of the transaction is relatively small compared to the total shares owned.

Positives

• An insider purchase by a director signals confidence in the company's future prospects.
• The acquisition increases the director's direct beneficial ownership, aligning his interests further with shareholders.

Future Outlook

The filing does not contain any explicit forward-looking statements or guidance.

Industry Context

Insider purchases, especially by directors, are often viewed positively by the market as they suggest management's belief in the company's undervaluation or strong future performance, potentially indicating a positive outlook for QuidelOrtho within the diagnostics and medical device industry.

Comparison to Industry Standards

• Not applicable. This filing reports an individual insider transaction and does not provide data for comparison to industry-wide financial or operational benchmarks.

Related Party Transactions

• Joseph D. Wilkins Jr., a Director of QuidelOrtho Corp, purchased common stock from the open market, which is considered a related party transaction under SEC rules for insider reporting.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management confidence, potentially leading to increased investor interest.
• Employees, customers, suppliers, and creditors are not directly impacted by this specific insider transaction, though a positive market sentiment could indirectly benefit them.

Key Dates

Recommendation

While an insider purchase is a positive signal, this transaction involves a relatively small number of shares (370) compared to the director's total holdings (11,876). It suggests confidence but isn't a strong enough signal on its own to warrant a 'buy' recommendation without further fundamental analysis. A 'hold' is appropriate as it reinforces existing positions but does not compel new investment based solely on this filing.

Keywords

QuidelOrtho, QDEL, Insider Trading, Director Purchase, Stock Acquisition, SEC Form 4, Beneficial Ownership, Joseph D. Wilkins Jr.